Emany Sravan Kumar
Insider CIK 1897662 · IRWD SVP, Chief Financial Officer · BEAM Chief Financial Officer · ASRT Director · KYTX Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ASRT Assertio Holdings, Inc. | D To issuer deriv | 2026-06-16 | 2026-06-16 | 5,415 | — | $0 | 0 | SEC↗ |
| ASRT Assertio Holdings, Inc. | D To issuer deriv | 2026-06-16 | 2026-06-16 | 5,415 | — | $0 | 0 | SEC↗ |
| ASRT Assertio Holdings, Inc. | D To issuer deriv | 2026-06-16 | 2026-06-16 | 1,753 | — | $0 | 0 | SEC↗ |
| ASRT Assertio Holdings, Inc. | U Tender | 2026-06-16 | 2026-06-16 | 23,855 | — | $0 | 0 | SEC↗ |
| ASRT Assertio Holdings, Inc. | A Award | 2026-05-05 | 2026-05-06 | 4,851 | — | $0 | 23,855 | SEC↗ |
| BEAM Beam Therapeutics Inc. | A Award | 2026-03-31 | 2026-04-02 | 31,750 | — | $0 | 105,456 | SEC↗ |
| KYTX Kyverna Therapeutics, Inc. | A Award deriv | 2026-02-24 | 2026-02-26 | 42,945 | — | $0 | 42,945 | SEC↗ |
| KYTX Kyverna Therapeutics, Inc. | A Award | 2026-02-24 | 2026-02-26 | 11,006 | — | $0 | 11,006 | SEC↗ |
| BEAM Beam Therapeutics Inc. | A Award deriv | 2026-01-31 | 2026-02-02 | 63,500 | — | $0 | 63,500 | SEC↗ |
| BEAM Beam Therapeutics Inc. | S Sale | 2025-12-31 | 2026-01-05 | 6,294 | $27.10 | $170.6K | 73,706 | SEC↗ |
| ASRT Assertio Holdings, Inc. | A Award deriv | 2025-05-07 | 2025-05-09 | 81,225 | — | $0 | 81,225 | SEC↗ |
| ASRT Assertio Holdings, Inc. | A Award | 2025-05-07 | 2025-05-09 | 53,750 | — | $0 | 285,070 | SEC↗ |
| BEAM Beam Therapeutics Inc. | A Award deriv | 2024-12-31 | 2025-01-02 | 160,000 | — | $0 | 160,000 | SEC↗ |
| BEAM Beam Therapeutics Inc. | A Award | 2024-12-31 | 2025-01-02 | 80,000 | — | $0 | 80,000 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | S Sale | 2024-11-18 | 2024-11-20 | 11,001 | $4.08 | $44.9K | 309,572 | SEC↗ |
| ASRT Assertio Holdings, Inc. | A Award deriv | 2024-05-23 | 2024-05-28 | 81,225 | — | $0 | 81,225 | SEC↗ |
| ASRT Assertio Holdings, Inc. | A Award | 2024-05-23 | 2024-05-28 | 53,750 | — | $0 | 231,320 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | F Tax w/h | 2024-05-16 | 2024-05-20 | 18,280 | $6.64 | $121.4K | 320,573 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | M Exercise deriv | 2024-03-08 | 2024-03-12 | 37,120 | — | $0 | 0 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | M Exercise | 2024-03-08 | 2024-03-12 | 37,120 | — | $0 | 338,853 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | P Buy | 2024-03-04 | 2024-03-06 | 10,684 | $9.38 | $100.2K | 301,733 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | A Award deriv | 2024-02-12 | 2024-02-14 | 32,656 | — | $0 | 32,656 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | A Award | 2024-02-12 | 2024-02-14 | 65,312 | — | $0 | 291,049 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | F Tax w/h | 2024-02-08 | 2024-02-12 | 41,332 | $14.90 | $615.8K | 225,737 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | A Award | 2024-01-17 | 2024-01-19 | 85,000 | — | $0 | 267,069 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | F Tax w/h | 2023-11-16 | 2023-11-20 | 6,661 | $9.44 | $62.9K | 182,069 | SEC↗ |
| ASRT Assertio Holdings, Inc. | A Award deriv | 2023-11-14 | 2023-11-16 | 26,308 | — | $0 | 26,308 | SEC↗ |
| ASRT Assertio Holdings, Inc. | A Award | 2023-11-14 | 2023-11-16 | 177,570 | — | $0 | 177,570 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | P Buy | 2023-09-15 | 2023-09-18 | 36,072 | $8.32 | $300.1K | 188,730 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | A Award deriv | 2023-03-08 | 2023-03-10 | 37,118 | — | $0 | 37,118 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | A Award | 2023-03-08 | 2023-03-10 | 74,236 | — | $0 | 152,658 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | S Sale | 2022-11-21 | 2022-11-23 | 6,578 | $11.56 | $76.0K | 78,422 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | A Award | 2021-12-06 | 2021-12-08 | 85,000 | — | $0 | 85,000 | SEC↗ |